Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2001
Randomized phase III trial of high-dose-intensity methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) chemotherapy and recombinant human granulocyte colony-stimulating factor versus classic MVAC in advanced urothelial tract tumors: European Organization for Research and Treatment of Cancer Protocol no. 30924C N Sternberg, P H de Mulder, J H Schornagel, et al.
European Stroke Journal|December 8, 2022
Near-infrared spectroscopy monitoring during endovascular treatment for acute ischaemic strokeSabine L Collette, Allart M Venema, Nick Eleveld, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Filgrastim during combination chemotherapy of patients with poor-prognosis metastatic germ cell malignancy. European Organization for Research and Treatment of Cancer, Genito-Urinary Group, and the Medical Research Council Testicular Cancer Working Party, Cambridge, United KingdomS D Fosså, S B Kaye, G M Mead, et al.
Oncology|March 3, 2005
Phase III trial of satraplatin, an oral platinum plus prednisone vs. prednisone alone in patients with hormone-refractory prostate cancerC N Sternberg, P Whelan, J Hetherington, et al.
European Journal of Cancer (Oxford, England : 1990)|April 23, 2003
Can patient-, treatment- and pathology-related characteristics explain the high local recurrence rate following breast-conserving therapy in young patients?C Vrieling, L Collette, A Fourquet, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 1, 1997
Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trialJ C Horiot, P Bontemps, W van den Bogaert, et al.
International Journal of Radiation Oncology, Biology, Physics|October 19, 1999
Validation of the methods of cosmetic assessment after breast-conserving therapy in the EORTC "boost versus no boost" trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. European Organization for Research and Treatment of CancerC Vrieling, L Collette, E Bartelink, et al.
European Journal of Cancer (Oxford, England : 1990)|December 7, 2005
Seven year update of an EORTC phase III trial of high-dose intensity M-VAC chemotherapy and G-CSF versus classic M-VAC in advanced urothelial tract tumoursC N Sternberg, P de Mulder, J H Schornagel, et al.
Stroke and Vascular Neurology|August 4, 2022
Intra-arterial thrombolytics during endovascular thrombectomy for acute ischaemic stroke in the MR CLEAN RegistrySabine L Collette, Reinoud P H Bokkers, Aryan Mazuri, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 2, 2008
The addition of a boost dose on the primary tumour bed after lumpectomy in breast conserving treatment for breast cancer. A summary of the results of EORTC 22881-10882 "boost versus no boost" trialP M Poortmans, L Collette, H Bartelink, et al.
Pageof 10